The use of P407 micelles in combination with FLT3 peptides could increase Dox uptake, resulting in increased Dox accumulation and the ability to destroy LSCs, which could be a selective approach for developing a new AML-LSC treatment strategy. The gene discussed is FLT3; the disease is acute myeloid leukemia.